Abiopharma

New Form 6-K - Haleon plc Filed: 2025-09-02 AccNo: 0001654954-25-010253 Size: 24 KB

Intensity Therapeutics, Inc. to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

Emergent BioSolutions Awarded $30 Million Contract Modification forCYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

New Form 8-K - Context Therapeutics Inc. Filed: 2025-09-02 AccNo: 0001842952-25-000085 Size: 148 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

First National Hand Health Month Empowers People to Live a Hands-On Life

Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025

Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak

MediWound

New Form 8-K - RELMADA THERAPEUTICS, INC. Filed: 2025-09-02 AccNo: 0001213900-25-082910 Size: 190 KB Item 7.01: Regulation FD Disclosure

Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement

Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team